Enzymatic Amplification of Platelet-Specific Messenger RNA Using the Polymerase Chain Reaction

Total Page:16

File Type:pdf, Size:1020Kb

Enzymatic Amplification of Platelet-Specific Messenger RNA Using the Polymerase Chain Reaction Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. P J Newman, … , C J Cretney, R H Aster J Clin Invest. 1988;82(2):739-743. https://doi.org/10.1172/JCI113656. Research Article Human platelets are derived from megakaryocytes as anucleate cells, and thus contain only vestigial amounts of RNA capable of being transcribed into protein. This has greatly hampered efforts to study directly platelet-specific gene products and their associated polymorphisms. In this report, we describe direct amplification, using the polymerase chain reaction, of platelet-derived mRNA in amounts sufficient to permit detailed analysis, such as restriction mapping and nucleotide sequencing. The ability to generate large amounts of cDNA from platelet-specific mRNA sequences should make possible direct molecular characterization of normal platelet proteins, and facilitate the investigation of a wide variety of inherited platelet disorders. Find the latest version: https://jci.me/113656/pdf Rapid Publication Enzymatic Amplification of Platelet-specific Messenger RNA Using the Polymerase Chain Reaction Peter J. Newman,** Jack Gorski, * Gilbert C. White 11,I Susan Gidwitz,I Connie J. Cretney, * and Richard H. Aster* *The Blood Center ofSoutheastern Wisconsin, Milwaukee, Wisconsin 53233; tDepartment ofAnatomy and Cellular Biology, The Medical College of Wisconsin, Milwaukee, Wisconsin 53226; §Department ofMedicine, The University ofNorth Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; and I1Departments ofMedicine and Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin 53226 Abstract from that of the analogue found in the nucleated cell from which the sequence was derived. Human platelets are derived from megakaryocytes as anu- It would be desirable to be able to study platelet-specific cleate cells, and thus contain only vestigial amounts of RNA gene sequences for a number of other reasons. Platelets express capable of being transcribed into protein. This has greatly a number of polymorphic epitopes on their surface that play hampered efforts to study directly platelet-specific gene prod- an important role in the etiology of alloimmune platelet dis- ucts and their associated polymorphisms. In this report, we orders (9, 10), and the molecular definition of alloantigenic describe direct amplification, using the polymerase chain reac- determinants would contribute to our understanding of the tion, of platelet-derived mRNA in amounts sufficient to permit morphological features of platelet antigens that are responsible detailed analysis, such as restriction mapping and nucleotide for eliciting an alloimmune response. These and other interest- sequencing. The ability to generate large amounts of cDNA ing platelet-related polymorphisms are often present in low from platelet-specific mRNA sequences should make possible frequency in the human population, making it nearly impossi- direct molecular characterization of normal platelet proteins, ble to predict or regulate the phenotypic makeup of a non- and facilitate the investigation of a wide variety of inherited platelet cDNA library. A preliminary report ( 11) suggests that platelet disorders. platelet mRNA can be prepared from individuals with myo- proliferative disorders in sufficient quantities to permit con- Introduction struction of a platelet-specific cDNA library, but it too would be limited in the number of polymorphic phenotypes repre- Human platelets contain more than 40 identifiable membrane sented. protein constituents, many of which have yet to be character- Recently, a method to enzymatically amplify short seg- ized. Since platelets are derived from megakaryocytes as non- ments of DNA has been developed (12-16). Known as the nucleated cells, it is generally believed that they possess only polymerase chain reaction (PcR),' this technique uses two vestigial amounts of protein-synthetic capability, although oligonucleotide primers to direct the repeated synthesis of specific protein biosynthesis in platelets has been demon- DNA bounded by their respective complementary sequences. strated ( 1-3 ). A primary deterrent to investigating the primary Since PcR has been reported to be capable of amplifying spe- structure of platelet-specific gene products has therefore been cific DNA sequences > 10 times, we decided to explore using the inability to obtain sufficient platelet mRNA to produce this method in the amplification of the vestigial amounts of cDNA libraries. A number of nucleated cell types have re- mRNA present in human platelets. In this report, we demon- cently been shown to synthesize proteins that are biochemi- strate that the RNA that can be derived from the platelets cally and immunologically related to their platelet counter- present in 50 ml of whole blood from normal individuals is parts (for a review, see reference 4), and cDNA libraries con- sufficient to produce microgram quantities of platelet-specific structed from these cells have been used to obtain the cDNA. This DNA is readily amenable to further detailed anal- nucleotide sequences of several platelet protein analogues ysis, including restriction mapping, subcloning, and nucleo- (5-8). Since these sequences are deduced from cDNA clones tide sequencing. derived from either transformed cell lines or cells of nonmega- karyocytic lineage, the possibility remains that the protein se- Methods quence of the actual platelet counterpart differs somewhat Materials. Taq DNA polymerase isolated from Thermus aquaticus Address reprint requests to Dr. Peter J. Newman, The Blood Center of was purchased from Perkin-Elmer Corp., Instrument Div., Norwalk, Southeastern Wisconsin, 1701 West Wisconsin Avenue, Milwaukee, CT. PGE,, Sarkosyl, and Antifoam A were obtained from Sigma WI 53233. Chemical Co., St. Louis, MO. Agarose used for preparative electropho- Received for publication 15 February 1988 and in revised form 7 resis was GTG-grade supplied by FMC Corp. Bioproducts, Rockland, April 1988. ME. Placental RNAse inhibitor (RNAsin) was purchased from Pro- mega Biotec, Madison, WI. Guanidinium isothiocyanate and cesium J. Clin. Invest. © The American Society for Clinical Investigation, Inc. 0021-9738/88/08/0739/05 $2.00 1. Abbreviations used in this paper: GP, glycoprotein; PcR, polymer- Volume 82, August 1988, 739-743 ase chain reaction; PRP, platelet-rich plasma. Enzymatic Amplification ofPlatelet Messenger RNA 739 chloride were purchased from Bethesda Research Laboratories, Gaith- formed directly in this tube using cloned M-MLV reverse transcriptase ersburg, MD. Southern blot hybridization was performed after transfer and a cDNA synthesis kit (Bethesda Research Laboratories) according to Genescreen Plus nylon membranes (Dupont Co., Diagnostic and to the manufacturer's directions, except that the oligonucleotide BioResearch Systems, Wilmington, DE). All other chemicals used primer PcR-2 was substituted for Oligo (dT)12-18 to direct only were of reagent grade. GPIIIa-specific first strand synthesis. The first strand reaction mix Isolation of platelet RNA. Human platelets were isolated from contained 50 mmol/liter Tris pH 8.3, 75 mmol/liter KCI, 3 mmol/ whole blood as previously described (17). Briefly, 50 ml of venous liter MgCl2, 10 mmol/liter DTT, 0.5 mmol/liter each of dATP, blood collected from healthy volunteer donors was anticoagulated with dGTP, dCTP, and dTTP, 1.0 Mmol/liter PcR-2 oligonucleotide, and 7 ml of acid citrate dextrose (National Institutes of Health, Formula 500 U M-MLV reverse transcriptase, in a final volume of 50 Ml. cDNA A), and PGEI was added to a final concentration of 50 nmol/liter. synthesis was carried out at 370C for 60 min, at which time the reac- Platelet-rich plasma (PRP) was prepared by differential centrifugation, tion was stopped by chilling to 0C. The first strand reaction mix was and the platelets present in the upper half of the PRP were harvested diluted with an equal volume of PcR dilution buffer (25 mmol/liter and washed an additional two times in wash buffer (100 mmol/liter KCI, 1 umol/liter PcR2 oligonucleotide, 2 Mmol/liter PcR-I oligonu- NaCl, 8.5 mmol/liter Tris, 8.5 mmol/liter glucose, and 1 mmol/liter cleotide, and 0.02% gelatin) and heated to 94°C for 2 min to separate Na2EDTA, pH 7.4). By carefully avoiding the lower half of the PRP, the strands. Samples were allowed to cool to 37°C, at which time 1 Al we were consistently able to achieve a platelet/leukocyte ratio of at (5 U) of Taq polymerase was added to initiate the polymerase chain least 3000:1. The final platelet pellet was solubilized in 3.3 ml of buffer reaction. Amplification was performed for 30 cycles, with 10-min composed of 4 mol/liter guanidinium isothiocyanate, 5 mmol/liter primer extensions at 72°C, denaturation for 1 min 20 s at 94°C, and sodium citrate, 0.1 mol/liter 2-mercaptoethanol, 0.5% Sarkosyl, 0.1% primer annealings for 3 min 20 s at 37°C. An additional 2.5 U of Taq Antifoam A, and 40 U/ml placental RNAse inhibitor, layered onto a polymerase was added after cycles 10 and 20. After the PcR, the am- 1.2-ml cushion of 5.7 mol/liter CsCl, and centrifuged at 20'C in a plified samples were stored at -20°C. TiSO. 1 rotor at 35,000 rpm for 16 h (Beckman Instruments, Inc. Ful- Analysis of PcR reaction products. 10-15 Ml of each 100-Mul PcR lerton, CA). The nearly invisible RNA pellet was resuspended in reaction was analyzed on a 1% agarose gel, followed by staining with buffer made up of 10 mmol/ liter Tris, 5 mmol/ liter EDTA, and 1% ethidium bromide. Positive identification of the resulting DNA bands SDS, pH 7.4), extracted with chloroform/butanol, and ethanol precip- as authentic derivatives of the mRNA encoding GPIIIa was obtained itated essentially as described by Maniatis et al. (18). The resulting by Southern blot analysis, using a cloned GPIIIa insert that runs from purified total platelet RNA fraction recovered using this technique was base 45 of the published sequence ( 5 ) to the internal Eco RI site at base <1 gg per individual, and was used in all subsequent steps without 2,274.
Recommended publications
  • SOP Template Northern Blotting with P-32
    Standard Operating Procedure Procedure Northern Blotting using 32P Department Location SOP Prepared By: Section 1: Purpose Northern blotting is a standard method for the detection and quantification of RNA from a cell. This is done by isolating and purifying RNA and using a radioactively-labeled DNA or RNA probe to hybridize to and detect the RNA. Using this technique, temporal and spatial location of RNA expression can be found8. Unlike RT-PCR (real-time PCR), which quantifies the amount of RNA or DNA at various times, Northern blotting can be used not only to quantify but also determine the size of the RNA. It is also useful to perform Northern blotting when studying transfer RNA (tRNA), which appears as the two lowest bands on a gel1. The probes used in Northern blotting do not have to be radioactive, but radioactive probes still have the greatest sensitivity. Quantifying mRNA of tRNA can provide insight into gene expression in cells that are exposed to different environments. Section 2: Personal Protective Equipment and Survey Equipment PPE: • Nitrile Gloves • Lab coat or lab gown • Proper enclosed shoes • Safety glasses Other Equipment: • Geiger counter • Personal chest dosimeter Section 3: Radioactive Material 32P, specific type varies according to what procedure is followed for probe design Supplier: Perkin Elmer Starting activity: 10 mCi/mL Typical use quantities: no more than 10uCi per experiment • Radioactive material (RAM) benchtop exposure time: ~10-20 minutes Activity used per experiment: _______________ RAM handling time: _______________ Frequency of experiment: _______________ Section 4: Potential Hazards • 32P is a high-energy beta emitter and has a half-life of 14.29 days.
    [Show full text]
  • Blotting Techniques Blotting Is the Technique in Which Nucleic Acids Or
    Blotting techniques Blotting is the technique in which nucleic acids or proteins are immobilized onto a solid support generally nylon or nitrocellulose membranes. Blotting of nucleic acid is the central technique for hybridization studies. Nucleic acid labeling and hybridization on membranes have formed the basis for a range of experimental techniques involving understanding of gene expression, organization, etc. Identifying and measuring specific proteins in complex biological mixtures, such as blood, have long been important goals in scientific and diagnostic practice. More recently the identification of abnormal genes in genomic DNA has become increasingly important in clinical research and genetic counseling. Blotting techniques are used to identify unique proteins and nucleic acid sequences. They have been developed to be highly specific and sensitive and have become important tools in both molecular biology and clinical research. General principle The blotting methods are fairly simple and usually consist of four separate steps: electrophoretic separation of protein or of nucleic acid fragments in the sample; transfer to and immobilization on paper support; binding of analytical probe to target molecule on paper; and visualization of bound probe. Molecules in a sample are first separated by electrophoresis and then transferred on to an easily handled support medium or membrane. This immobilizes the protein or DNA fragments, provides a faithful replica of the original separation, and facilitates subsequent biochemical analysis. After being transferred to the support medium the immobilized protein or nucleic acid fragment is localized by the use of probes, such as antibodies or DNA, that specifically bind to the molecule of interest. Finally, the position of the probe that is bound to the immobilized target molecule is visualized usually by autoradiography.
    [Show full text]
  • Near-Infrared Fluorescent Northern Blot
    Downloaded from rnajournal.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press METHOD Near-infrared fluorescent northern blot BRET R. MILLER,1,4 TIANQI WEI,1,4 CHRISTOPHER J. FIELDS,1,2 PEIKE SHENG,1,2 and MINGYI XIE1,2,3 1Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610, USA 2UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, USA 3UF Genetics Institute, University of Florida, Gainesville, Florida 32610, USA ABSTRACT Northern blot analysis detects RNA molecules immobilized on nylon membranes through hybridization with radioactive 32P-labeled DNA or RNA oligonucleotide probes. Alternatively, nonradioactive northern blot relies on chemiluminescent reactions triggered by horseradish peroxidase (HRP) conjugated probes. The use of regulated radioactive material and the complexity of chemiluminescent reactions and detection have hampered the adoption of northern blot techniques by the wider biomedical research community. Here, we describe a sensitive and straightforward nonradioactive northern blot method, which utilizes near-infrared (IR) fluorescent dye-labeled probes (irNorthern). We found that irNorthern has a detection limit of ∼0.05 femtomoles (fmol), which is slightly less sensitive than 32P-Northern. However, we found that the IR dye-labeled probe maintains the sensitivity after multiple usages as well as long-term storage. We also present al- ternative irNorthern methods using a biotinylated DNA probe, a DNA probe labeled by terminal transferase, or an RNA probe labeled during in vitro transcription. Furthermore, utilization of different IR dyes allows multiplex detection of dif- ferent RNA species. Therefore, irNorthern represents a more convenient and versatile tool for RNA detection compared to traditional northern blot analysis.
    [Show full text]
  • NORTHERN BLOT SEM.I Dr.Ramesh Pathak the Northern Blot Is Also
    NORTHERN BLOT SEM.I Dr.Ramesh Pathak The Northern blot is also called RNA blot. It is a technique used in molecular biology to study gene expression by detection of RNA in a sample. The northern blot technique developed by James Alwine, David Kemp and Jeorge Stark at Stanford University with contribution from Gerhard Heinrich in 1977.Northern blotting takes its name from its similarity to the first blotting technique, the southern blotting named after biologist Edwin Southern. Procedure The blotting process starts with extraction of total RNA from a homogenized tissue sample or cells on agarose gel containing formaldehyde which is a denaturing agent for the RNA to limit secondary structure. Eukaryotic mRNA can then be isolated through the use of oligo(dT) cellulose chromatography to isolate only those RNAs with a poly A tail. RNA samples are then separated by gel electrophoresis. Since the gels are fragile and the probes are unable to enter matrix, the RNA samples, now separated by size, are transferred to nylon membrane through a capillary or vacuum blotting system. A nylon membrane with a positive charge, is the most effective for use in northern blotting since the negatively charged nucleic acids have a high affinity for them. The transfer buffer used for the blotting usually contain formamide because it lowers the annealing temperature of the probe-RNA interaction, thus eliminating the need for high temperature, which could cause RNA degradation. Once the RNA has been transferred to the membrane, it is immobilized through covalent linkage to the membrane by UV light or heat.
    [Show full text]
  • Blotting Techniques M.W
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector RESEARCH TECHNIQUES MADE SIMPLE North, South, or East? Blotting Techniques M.W. Nicholas1 and Kelly Nelson2 Journal of Investigative Dermatology (2013) 133, e10; doi:10.1038/jid.2013.216 One of the cornerstones of modern molecular biology, blotting is a powerful and sensitive technique for identifying WHAT BLOTTING DOES the presence of specific biomolecules within a sample. • Blotting allows specific and sensitive detection of a Subtypes of blotting are differentiated by the target protein (western) or specific DNA or RNA sequence molecule that is being sought. The first of these tech­ (Southern, northern) within a large sample isolate. niques developed was the Southern blot, named for Dr. • Targets are first separated by size/charge via gel Edwin Southern, who developed it to detect specific DNA electrophoresis and then identified using a very sequences (Southern, 1975). Subsequently, the method was sensitive probe. modified to detect other targets. The nomenclature of these • Variations of these techniques can detect post­ techniques was built around Dr. Southern’s name, resulting translational modifications and DNA­bound proteins. in the terms northern blot (for detection of RNA), western blot (for detection of protein), eastern blot (for detection • Western blotting may also be used to detect a of posttranslationally modified proteins), and south­ circulating antibody in a patient sample or confirm western blot (for detection of DNA binding proteins). Most an antibody’s specificity. researchers consider the eastern blot and the southwestern blot variations of western blots rather than distinct entities.
    [Show full text]
  • High-Resolution Northern Blot for a Reliable Analysis of Micrornas and Their Precursors
    Peer-Reviewed Protocol TheScientificWorldJOURNAL (2011) 11, 102–117 ISSN 1537-744X; DOI 10.1100/tsw.2011.11 High-Resolution Northern Blot for a Reliable Analysis of MicroRNAs and Their Precursors Edyta Koscianska, Julia Starega-Roslan, Katarzyna Czubala, and Wlodzimierz J. Krzyzosiak* Laboratory of Cancer Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland E-mail: [email protected]; [email protected]; [email protected]; [email protected] Received November 4, 2010; Revised December 2, 2010; Accepted December 2, 2010; Published January 5, 2011 This protocol describes how to perform northern blot analyses to detect microRNAs and their precursors with single-nucleotide resolution, which is crucial for analyzing individual length variants and for evaluating relative quantities of unique microRNAs in cells. Northern blot analysis consists of resolving RNAs by gel electrophoresis, followed by transferring and fixing to nylon membranes as well as detecting by hybridization with radioactive probes. Earlier efforts to improve this method focused mainly on altering the sensitivity of short RNA detection. We have enhanced the resolution of the northern blot technique by optimizing the electrophoresis step. We have also investigated other steps of the procedure with the goal of enhancing the resolution of RNAs; herein, we present several recommendations to do so. Our protocol is applicable to analyses of all kinds of endogenous and exogenous RNAs, falling within length ranges of 20–30 and 50–70 nt, corresponding to microRNA and pre-microRNA lengths, respectively. KEYWORDS: northern blotting, single-nucleotide resolution, miRNA, pre-miRNA, miRNA length heterogeneity INTRODUCTION MicroRNAs (miRNAs) are well-known post-transcriptional regulators of gene expression found in all multicellular organisms.
    [Show full text]
  • Southern, Northern, and Western Blots
    Southern, Northern, and Western Blots Southern blotting: The Southern blot (named for its inventor) uses gel electrophoresis together with hybridization probes to characterize DNA restriction fragments. Genomic DNA or DNA from a specific source, such as a lambda phage or cosmid clone, is digested, usually to completion, with a restriction endonuclease (or sometimes with two or more restriction endonucleases). Electrophoresis is then used to separate the fragments by size. The fragments are then blotted from the electrophoretic gel onto a sheet of nitrocellulose or similar support material, and fixed onto it by heating or other treatments. The attached DNA fragments are denatured to separate the strands and annealed with a radioactive probe that is single stranded or also denatured. The nitrocellulose sheet is then washed, removing all unbound probe, and leaving radioactivity only where the probe has hybridized to the original DNA bound to the membrane. A sheet of X-ray film is then laid over the nitrocellulose for a time period long enough for the radioactivity to "expose" the film. When the film is developed, dark bands appear wherever there were DNA fragments capable of hybridizing with the radioactive probe. Size standards run on the same electrophoretic gel allow the sizes of the fragments identified by the probe to be determined (figure 9.31). Interpreting Southern blots: Matching the positions of the radioactive spots with those of the size standards identifies the sizes of the digestion fragments that hybridize with the probe. For example, a cDNA probe for a gene that contains two internal cut sites for the restriction enzyme will generate three fragments (which will usually have enough size difference so that all three can be detected).
    [Show full text]
  • Northern Blotting
    NORTHERN BLOTTING Prepared by Dr. Subhadeep Sarker Associate Professor, Department of Zoology for UG & PG Studies, Serampore College • The technique was developed by James Alwine, David Kemp, and George Stark at Stanford University in 1977. • The Northern blot is used to detect the presence of particular mRNA in a sample. • The term “Northern” has no scientific significance. It was given in connection with the name of blotting of DNA which is known as Southern Blotting after the name of the discoverer E. M. Southern. Dr. Subhadeep Sarker • Principle: The key to this method is transfer of RNA from gel followed by nucleic acid hybridization, which is the process of forming a double-stranded DNA-RNA hybrid molecule between a single-stranded DNA probe and a single-stranded target RNA. • The reactions are very specific – the probes will only bind to specific target with a complementary sequence. The probe can find one molecule of target in a mixture of millions of related but non-complementary molecules. Dr. Subhadeep Sarker PROCEDURE • Northern blotting procedure starts with extraction of total RNA from a homogenized tissue sample or from cells. Eukaryotic mRNA molecules can then be isolated through the use of oligo- dT cellulose chromatography to isolate only those RNAs with a polyA tail. • RNA samples are then separated by gel electrophoresis. The RNA samples are most commonly separated on agarose gels containing formaldehyde as a denaturing agent for the RNA to limit secondary structure. • The gels can be stained with ethidium bromide (EtBr) and viewed under UV light to observe the quality and quantity of RNA before blotting.
    [Show full text]
  • NORTHERN BLOT HYBRIDIZATION of RNA (ZETA-PROBE MEMBRANE) A. RNA Gel Electrophoresis 1. Gel Preparation: Determine Amounts of A
    NORTHERN BLOT HYBRIDIZATION OF RNA (ZETA-PROBE MEMBRANE) A. RNA gel electrophoresis 1. Gel preparation: Determine amounts of agarose, 10X MOPS buffer, 37% formaldehyde, and ddH20 to make a 1.2% agarose gel with final concentrations of 1X MOPS/6.3% formaldehyde. Melt the agarose in the ddH2O + 10X MOPS and cool to 65˚ C. Then add formaldehyde and pour gel (in hood, fumes will be strong). Cover gel with saran wrap when hardened if not using immediately - don’t let it dry out. The gel should be as thin as possible. 2. Sample preparation: RNA samples should be resuspended in ddH2O in a final volume of 3.5 µl (keep on ice until denatured). To each sample, add 5 µl formamide, 1.5 µl 10X MOPS buffer, and 2 µl 37% formaldehyde. (N.B. The formamide/10X MOPS/formaldehyde solution can be premixed in bulk and 8.5 µl added to each sample.) 3. Heat RNAs 5 min at 65˚ C to denature, chill on ice. Add 2 µl of dye mix and load onto gel. 4. Electrophorese at 5 V/cm (or less) with buffer recirculation. 5. Transfer the gel by capillary action overnight to Zeta-Probe (BioRad) in 10X SSC. Wet membrane in water, then 2X SSC for 5 min. before transfer (also wet top Whatman papers in 2X SSC). 6. After transfer, rinse blot in 2X SSC to remove any adhering agarose. Let air dry until just damp. Expose the blot to UV light (Stratalinker) to crosslink the nucleic acid to the membrane. The blot is now ready for prehybridization.
    [Show full text]
  • Northern Blotting
    Proceedings of the Nutrition Society (1996), 55, 583-589 583 Northern blotting BY PAUL TRAYHURN Division of Biochemical Sciences, Rowett Research Institute, Bucksburn, Aberdeen AB2 9SB INTRODUCTION: WHY MEASURE AN mRNA? Northern blotting is one of the key techniques in molecular biology, its principal aim being the measurement of a specific messenger RNA (mRNA). Before discussing Northern blotting in detail, it is appropriate to consider the question of why one should wish to measure an mRNA. There are in practice two main reasons. The first is to determine which tissues express a particular gene, and this can give some indication of the physiological function of the encoded protein. For example, the recently-described ob (obese) gene is expressed in white adipose tissue, which is the basis for the view that the protein product (leptin) acts as a signal for the size of the fat depots. The second principal reason for measuring an mRNA is to determine the factors which regulate the expression of a given gene, be they nutritional, hormonal, or environmental. There are three techniques for measuring an mRNA. The first, and most extensively used, is Northern blotting. A second method is the RNase protection assay, which is generally considered to offer improved sensitivity. The third method utilizes the reverse transcriptase polymerase chain reaction; this provides considerable increases in sensitivity over Northern blotting and the RNase protection assay, and may be useful for measuring very low levels (a few copies) of an mRNA in a tissue. Given that Northern blotting is the principal method of measuring an mRNA, this technique is outlined in the present paper.
    [Show full text]
  • (Subunit C) of Pleurochrysis
    J. Phycol. 40, 82–87 (2004) r 2004 Phycological Society of America DOI: 10.1046/j.1529-8817.2004.02154.x EFFECTS OF NITROGEN AND PHOSPHORUS AVAILABILITY ON THE EXPRESSION OF THE COCCOLITH-VESICLE V-ATPASE (SUBUNIT C)OF PLEUROCHRYSIS (HAPTOPHYTA)1 Paul L. A. M. Corstjens2 and Elma L. Gonza´lez3 Department of Organismic Biology, Ecology and Evolution, University of California, Los Angeles, Los Angeles, California 90095-1606, USA The coccolithophores Emiliania and Pleurochry- with season, depth, and proximity to land masses sis demonstrate increased coccolith production (Millero 1996, Varela and Harrison 1999). Phosphate con- when growth is reduced by nitrate or phosphate centrations range about 10-fold lower than nitrate limitation. The function of enhanced coccolith levels. A number of coccolithophorid species have production under these conditions and its regula- adapted to survive at nitrate levels below 0.5 mM and tion have not been resolved. Studies at the molecular phosphate levels below 0.02 mM (Cortes et al. 2001, level are ideally suited to determine the exact Haidar and Thierstein 2001). The relationship be- relationship between calcification and other cellular tween nutrient availability, principally nitrogen and functions. In a previous study we provided evidence phosphorous, to rates of calcification among cocco- for the presence of a vacuolar H þ -ATPase on lithophores has only been examined in the laboratory. coccolith vesicle membranes of P. carterae. These In nearly all cases, the coccolithophore strain or species trans-Golgi–derived vesicles are the sites of cocco- examined exhibited greater rates of calcification when lith production, with each vesicle containing one placed under nitrogen limitation (Baumann et al.
    [Show full text]
  • Expression and Replication of Virus-Like Circular DNA in Human Cells
    www.nature.com/scientificreports OPEN Expression and replication of virus- like circular DNA in human cells Sebastian Eilebrecht 1, Agnes Hotz-Wagenblatt2, Victor Sarachaga1,3, Amelie Burk1,3, Konstantina Falida1, Deblina Chakraborty1, Ekaterina Nikitina1,4,5, Claudia Tessmer6, 1 1 1 1 1 Received: 29 August 2017 Corinna Whitley , Charlotte Sauerland , Karin Gunst , Imke Grewe & Timo Bund Accepted: 2 February 2018 The consumption of bovine milk and meat is considered a risk factor for colon- and breast cancer Published: xx xx xxxx formation, and milk consumption has also been implicated in an increased risk for developing Multiple Sclerosis (MS). A number of highly related virus-like DNAs have been recently isolated from bovine milk and sera and from a brain sample of a MS patient. As a genetic activity of these Acinetobacter-related bovine milk and meat factors (BMMFs) is unknown in eukaryotes, we analyzed their expression and replication potential in human HEK293TT cells. While all analyzed BMMFs show transcriptional activity, the MS brain isolate MSBI1.176, sharing homology with a transmissible spongiform encephalopathy- associated DNA molecule, is transcribed at highest levels. We show expression of a replication- associated protein (Rep), which is highly conserved among all BMMFs, and serological tests indicate a human anti-Rep immune response. While the cow milk isolate CMI1.252 is replication-competent in HEK293TT cells, replication of MSBI1.176 is complemented by CMI1.252, pointing at an interplay during the establishment of persistence in human cells. Transcriptome profling upon BMMF expression identifed host cellular gene expression changes related to cell cycle progression and cell viability control, indicating potential pathways for a pathogenic involvement of BMMFs.
    [Show full text]